Published September 15, 2022 | Version v1

An anti-influenza combined therapy assessed by single cell RNA-sequencing

  • 1. Department of Microbiology and Molecular Medicine, University of Geneva, Geneva 1206 Switzerland
  • 2. Health 2030 Genome Center, Geneva 1202, Switzerland
  • 3. Insitute of Materials, Ecole Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland
  • 4. Epithelix Sas, Geneva 1228, Switzerland
  • 5. Faculty of Biology and Medicine, Université de Lausanne, Lausanne 1011, Switzerland

Description

Figures source data

 

Files

Files (12.0 MB)

Name Size Download all
md5:83f20ecd77d7410f6fadf95bd5fe7641
10.2 MB Download
md5:7c6d33c3833a1077735aafac398db329
1.7 MB Download
md5:b2bd2263689075eef8d7fa6a33b84095
35.3 kB Download
md5:3efca411706c70251effa51a84023e9a
15.9 kB Download